rc 3095 has been researched along with Neuroblastoma in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Abujamra, AL; Almeida, VR; Brunetto, AL; Roesler, R; Schwartsmann, G | 1 |
| Baregamian, N; Chung, DH; Evers, BM; Ishola, TA; Kang, J; Mourot, JM; Rychahou, PG | 1 |
2 other study(ies) available for rc 3095 and Neuroblastoma
| Article | Year |
|---|---|
A gastrin-releasing peptide receptor antagonist stimulates Neuro2a neuroblastoma cell growth: prevention by a histone deacetylase inhibitor.
Topics: Animals; Bombesin; Butyrates; Cell Proliferation; Gene Knockdown Techniques; Histone Deacetylase Inhibitors; Histone Deacetylases; Humans; Mice; Neuroblastoma; Peptide Fragments; Receptors, Bombesin; Tumor Cells, Cultured | 2009 |
Bombesin induces angiogenesis and neuroblastoma growth.
Topics: Animals; Anticarcinogenic Agents; Bombesin; Cell Line, Tumor; Cell Proliferation; Gastrin-Releasing Peptide; Humans; Male; Mice; Mice, Nude; Neoplasm Transplantation; Neovascularization, Pathologic; Neuroblastoma; Peptide Fragments; Receptors, Bombesin; RNA, Small Interfering; Vascular Endothelial Growth Factor A | 2007 |